BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12112028)

  • 1. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.
    Bosc DG; Janknecht R
    J Cell Biochem; 2002; 86(1):174-83. PubMed ID: 12112028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.
    Dowdy SC; Mariani A; Janknecht R
    J Biol Chem; 2003 Nov; 278(45):44377-84. PubMed ID: 12947087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.
    Bosc DG; Goueli BS; Janknecht R
    Oncogene; 2001 Sep; 20(43):6215-24. PubMed ID: 11593430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.
    Goel A; Janknecht R
    Mol Cell Biol; 2003 Sep; 23(17):6243-54. PubMed ID: 12917345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
    Goueli BS; Janknecht R
    Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.
    Papoutsopoulou S; Janknecht R
    Mol Cell Biol; 2000 Oct; 20(19):7300-10. PubMed ID: 10982847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.
    Goel A; Janknecht R
    J Biol Chem; 2004 Apr; 279(15):14909-16. PubMed ID: 14747462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.
    Wu J; Janknecht R
    J Biol Chem; 2002 Nov; 277(45):42669-79. PubMed ID: 12213813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1).
    Janknecht R
    Oncogene; 2003 Feb; 22(5):746-55. PubMed ID: 12569367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
    Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
    Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2.
    Janknecht R
    J Biol Chem; 2001 Nov; 276(45):41856-61. PubMed ID: 11551945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
    Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
    Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the ERK-stimulated ETS transcription factor ER81.
    Janknecht R
    Mol Cell Biol; 1996 Apr; 16(4):1550-6. PubMed ID: 8657129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.
    Shin S; Bosc DG; Ingle JN; Spelsberg TC; Janknecht R
    J Cell Biochem; 2008 Oct; 105(3):866-74. PubMed ID: 18726892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
    Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
    J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
    Foulds CE; Nelson ML; Blaszczak AG; Graves BJ
    Mol Cell Biol; 2004 Dec; 24(24):10954-64. PubMed ID: 15572696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
    Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T
    Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides.
    Chiang SY; Burli RW; Benz CC; Gawron L; Scott GK; Dervan PB; Beerman TA
    J Biol Chem; 2000 Aug; 275(32):24246-54. PubMed ID: 10818092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.